Companies / Lyell Immunopharma, Inc. / Activity
Activity — Lyell Immunopharma, Inc.
5 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 11, 2026 | Seely Lynn CEO | Sell | Common Stock | $174.4K | -7K -9.12% | 74,266 0.30% of shares | medium |
| Feb 10, 2026 | Seely Lynn CEO | Sell | Common Stock | $10.1K | -438 -0.53% | 81,721 0.33% of shares | low |
| May 11, 2026 | Seely Lynn CEO | Sell | Common Stock | $7.3K | -388 -0.52% | 73,878 0.30% of shares | low |
| Feb 9, 2026 | Seely Lynn CEO | Grant | Common Stock | $0 | +20K +32.18% | 82,159 0.34% of shares | low |
| Feb 10, 2026 | Seely Lynn CEO | Grant | Option (right to buy) | — | +155K | 155,000 0.63% of shares | low |